NHL-BFM-90 Regimen

Known as: BFM-90 Regimen 
A regimen used for the treatment of localized aggressive forms of childhood B-cell non-Hodgkin's lymphoma, including lymphoblastic lymphoma.
National Institutes of Health

Topic mentions per year

Topic mentions per year

2004-2017
0120042017

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
AIM To estimate the number of early progenitors of bone marrow (BM) hematopoiesis in patients with diffuse large B-cell lymphoma… (More)
Is this relevant?
2016
2016
AIM to provide the clinical characteristics of patients with diffuse large B-cell lymphoma (DLBCL) with monoclonal immunoglobulin… (More)
Is this relevant?
2016
2016
AIM to evaluate late myelotoxicity (MT) relate to high-dose chemotherapy (CT) according to the modified NHL-BFM-90 (mNHL-BFM-90… (More)
Is this relevant?
2015
2015
AIM To evaluate the late cardiotoxicity (CT) of high-dose chemotherapy (CT) according to the modified NHL-BFM-90 (mNHL-BFM-90… (More)
Is this relevant?
2012
2012
AIM To evaluate the efficiency of intensive polychemotherapy (PCT) in adult patients having diffuse large B-cell lymphoma (DLBL… (More)
Is this relevant?
2011
2011
AIM To ascertain indications to standard (CHOP-21/R-CHOP-21) and intensive (mNHL-BFM-90) treatment in patients with diffuse large… (More)
Is this relevant?
2009
2009
AIM To evaluate efficacy of intensive modified program NHL-BFM-90 (mNHL-BFM-90) in adult poor-prognosis patients with diffuse… (More)
Is this relevant?
2008
2008
AIM To compare efficacy and toxicity of conservative therapy (different programs of polychemotherapy) of gastric lymphosarcoma… (More)
Is this relevant?
2004
2004
BACKGROUND & OBJECTIVES B cell non-Hodgkin's lymphoma (B-NHL) in childhood and adolescence is aggressive. Routine CHOP regimen… (More)
Is this relevant?